Letters Archives – Treatment Action Group

An Open Letter to Médecins Sans Frontières — Urgent Call to Reverse the Devastating Decision to Shutter the MSF Access Campaign

June 20, 2024
Dorrit Walsh

TAG's emergency plea to our allies at MSF to preserve its life-saving and world-changing MSF Access Campaign (Campaign for Access to Essential Medicines) — we need them now more than ever!

Comments Delivered at the WHO Director-General’s TB Vaccine Accelerator Council

May 30, 2024
Dorrit Walsh

These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 2nd meeting of the WHO Director-General’s TB Vaccine Accelerator Council in Geneva Switzerland.

TAG Comments at UN High-Level Meeting on Antimicrobial Resistance Hearing

May 17, 2024
Dorrit Walsh

TAG delivered an intervention at the UN High-Level Meeting on Antimicrobial Resistance (AMR) Multistakeholder Hearing, calling on member states to incorporate drug-resistant TB (DR-TB) in the political declaration as a key component of AMR response.

Submission on the Right to Access and Take Part in Scientific Progress

November 16, 2023
Dorrit Walsh

TAG is a longstanding champion of the human right to science, which we believe entitles everyone, everywhere to benefit from the best available tools to end HIV, TB, and HCV.

Letter to Dr. Jeanne Marazzo, New Director NIAID

August 10, 2023
Dorrit Walsh

We're excited to welcome Dr. Jeanne Marazzo as the first woman and openly LGBTQ+ Director of the National Institute of Allergy and Infectious Diseases (NIAID).

Open letter: Requesting Clarification on the Recent Deal on Generic Bedaquiline Supply

August 1, 2023
Dorrit Walsh

TAG, Partners In Health, and MSF Access Campaign sent an open letter to Johnson & Johnson requesting detailed responses to questions and concerns regarding the deal with the Global Drug Facility to supply generic bedaquiline to low- and middle-income countries that excludes South Africa, 10 EECA countries, and China.

Open Letter: Urgent Action Necessary for Equitable Access to Bedaquiline in All Countries with High Burdens of TB, MDR-TB, and TB/HIV

July 11, 2023
Dorrit Walsh

TAG and 82 other organizations and 106 individuals representing TB-affected communities and civil society sent an open letter to Johnson & Johnson calling on the company...

TAG’s Submission to OHCHR for GA78 Report

May 19, 2023
Dorrit Walsh

TAG recently submitted this input for the Office of the High Commissioner on Human Rights (ONHCR) Independent Expert on Foreign Debt and Human Rights thematic report for the UN General Assembly 78 later this year.

Open Letter: Urgent Action Necessary to Improve Equitable Access to Bedaquiline-Based Regimens and Achieve 1/4/6×24

January 13, 2023
Dorrit Walsh

TAG and a coalition of civil society activists, public health leaders, and researchers acting in solidarity with communities affected by tuberculosis sent an open letter to Johnson & Johnson calling on the company to publicly commit to withdraw and not…

Public Comment Submitted to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)

November 10, 2022
Dorrit Walsh

Comment submitted prior to their meeting on November 17, 2022. Comment is in regard to discussion and voting on recommendation related to implementation of the HIV Organ Policy Equity (HOPE) Act of 2013, specifically pertaining to HIV-positive to HIV-positive organ transplantation and pertaining to the following draft recommendation under consideration regarding removal of the statutory “NIH Research Criteria and IRB” requirement.